# Cobenfy

NDC: 0003-5200
Generic name: xanomeline and trospium chloride
Labeler / Manufacturer: E.R. Squibb & Sons, L.L.C.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: —
Marketing started: 20240927

FDA application: NDA216158

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0003-5200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0003-5200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f0e73bf-6025-44f6-ab64-0983322de0df